CA2045524A1 - Proteines diagnostiques pour la recherche de plus d'un anticorps - Google Patents

Proteines diagnostiques pour la recherche de plus d'un anticorps

Info

Publication number
CA2045524A1
CA2045524A1 CA 2045524 CA2045524A CA2045524A1 CA 2045524 A1 CA2045524 A1 CA 2045524A1 CA 2045524 CA2045524 CA 2045524 CA 2045524 A CA2045524 A CA 2045524A CA 2045524 A1 CA2045524 A1 CA 2045524A1
Authority
CA
Canada
Prior art keywords
hiv
peptide fragment
htlv
virus
immunodiagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2045524
Other languages
English (en)
Inventor
Elihu M. Young
James R. Storey
Gerald A. Beltz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2045524A1 publication Critical patent/CA2045524A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA 2045524 1989-11-13 1990-11-13 Proteines diagnostiques pour la recherche de plus d'un anticorps Abandoned CA2045524A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43370989A 1989-11-13 1989-11-13
US433,709 1989-11-13

Publications (1)

Publication Number Publication Date
CA2045524A1 true CA2045524A1 (fr) 1991-05-14

Family

ID=23721245

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2045524 Abandoned CA2045524A1 (fr) 1989-11-13 1990-11-13 Proteines diagnostiques pour la recherche de plus d'un anticorps

Country Status (5)

Country Link
EP (1) EP0453563A4 (fr)
JP (1) JPH04502773A (fr)
CA (1) CA2045524A1 (fr)
IE (1) IE904083A1 (fr)
WO (1) WO1991007664A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6846905B2 (en) * 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US6656906B1 (en) 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6258782B1 (en) 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
IES20020938A2 (en) * 2002-12-03 2003-11-12 Trinity Res Ltd A test for detection of antibodies to HIV

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use

Also Published As

Publication number Publication date
EP0453563A4 (en) 1991-11-06
JPH04502773A (ja) 1992-05-21
WO1991007664A1 (fr) 1991-05-30
IE904083A1 (en) 1991-05-22
EP0453563A1 (fr) 1991-10-30

Similar Documents

Publication Publication Date Title
US4753873A (en) Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
EP0233045B1 (fr) Peptides pour le diagnostic des anticorps HTLV-III, ainsi que leur préparation et leur utilisation
US4629783A (en) Synthetic antigen for the detection of AIDS-related disease
EP0201588B1 (fr) Analyse de detection d'une infection par un virus lymphotrophique de cellules t humaines
JP3073752B2 (ja) Hivエンベロープタンパク質およびそれを用いたhiv抗原に対する抗体の検出方法
US4784941A (en) Expression and diagnostic use of pENV-3 encoded peptides which are immunologically reactive with antibodies to LAV
US5075211A (en) Synthetic antigen for the detection of AIDS-related disease
CA2045524A1 (fr) Proteines diagnostiques pour la recherche de plus d'un anticorps
EP0284383B1 (fr) Antigènes synthétiques pour la détection de maladies liées au SIDA causées par LAV-2
WO1991013360A1 (fr) NOUVEAUX PEPTIDES D'HIV p24, ANTIGENES DIAGNOSTIQUES ET METHODE D'IMMUNO-ANALYSE DISCRIMINANTE
AU627738B2 (en) Htlv-i / hiv-1 fusion proteins
EP1878805B1 (fr) Antigène de synthèse pour la détection d'anticorps présentant une immunoréactivité vis-à-vis du virus VIH
WO1991007510A1 (fr) Methode de detection d'anticorps htlv-i dans les fluides corporels humains
AU623949B2 (en) Synthetic peptide derivatives of gp41 glycoprotein of HIV
Sohn et al. Overexpression and purification of human immunodeficiency virus type 1 env derived epitopes in Escherichia coli
US20030054336A1 (en) Method for detecting hiv antibodies and antigens used to this end
CA1247082A (fr) Essai de depistage de l'infection par le virus de la leucemie a cellules t humaines
Marczinovits et al. Expression in Escherichia coli and in vitro processing of HIV-1 p24 fusion protein
AU614971B2 (en) Hiv polypeptide, its preparation and use in detection of hiv antibodies
CA2004287A1 (fr) Peptide
WO1996012023A1 (fr) Proteine recombinee appelee dev-1 utilisee pour detecter le vih, sequence d'adn codant cette proteine, et dosages immunologiques realises au moyen de cette proteine
CA2575000A1 (fr) Genes env de synthese vih-1 et vih-2 pour l'optimisation de l'expression des bacteries destines aux immuno-essais des anticorps anti-vih

Legal Events

Date Code Title Description
FZDE Dead